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INTRODUCTION
The incidence of colorectal cancer in Japan has
increased over the past four decades, and it was sug-
gested that this increase is linked to increased con-
sumption of Western foods characterized by high-fat
and less fiber diets. Such dietary habits are known
to be correlated with high fecal concentrations of bile
acids. In agreement with this, epidemiological studies
showed that fecal concentrations of bile acids were
high in patients with colon cancer as well as in people
from countries with a high incidence of colon can-
cer (1, 2). Thus, all these findings suggest that a strong
relation between fecal bile acids and human colon
carcinogenesis. Bile acids have also been studied
extensively in animal models of colon cancer (3-
5). In our previous studies, the effects of human bile
acids on azoxymethane (AOM)-induced aberrant
crypt foci (ACF), which is a good surrogate marker
for colon carcinogenesis, were investigated in the rat
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colon (6, 7). In these studies using dietary intake and
intracolonic administration of bile acids, ursodeoxycholic
acid (UDCA) showed a significant suppressive effect
on ACF formation, whereas other bile acids, i.e. cholic
acid (CA), deoxycholic acid (DCA), chenodeoxycholic
acid (CDCA) and lithocholic acid (LCA), showed
either promotive effects or no effect on the colonic
mucosa. The preventive effect of UDCA on colonic
tumor formation was also demonstrated in rats (5).
Although controversies continue with respect to find-
ing a correlation between the ACF parameters and
tumor outcome, as a precursor lesion of the colon
cancer (8, 9), it has been established that ACF is a
good biomarker to assess the effects of colon carcino-
gens as well as chemopreventive agents (10, 11).
UDCA may be one of the hopeful chemopreventive
agents for high-risk groups for colon cancer. In the
present study, the effects of UDCA in different stages
of colon carcinogenesis by AOM treatment were ex-
amined in Fischer 344 (F344) rat colon and the
time-course and dose-response of the effects of UDCA
on ACF formation were also examined.
Although, the bile acids are greatly involved in
the development of colon tumors and ACF, the exact
mechanism of the bile acids action remains unclear.
Increasing evidence suggests that colonic malignant
transformation involves various mutations activating
proto-oncogenes such as K-ras (12), inactivating
tumor suppressor genes such as p53 and APC (13),
and inactivating genes involved in DNA mismatch
repair. On the other hand, epigenetic changes in sig-
nal transduction elements, such as protein kinase
C (PKC) may also be involved in multistage process-
es of colon carcinogenesis (14, 15). Bile acids, which
have various effects on colonic ACF formation, are
also known activators of PKC that have been impli-
cated in the development of colonic carcinoma (16).
Since PKC is activated by intracellular calcium ions,
it is possible to have an association between the ef-
fect of bile acids and their intracellular calcium in-
duction. It was also reported that calcium ions (Ca2+)
are a versatile mediator of many cellular biological
processes, including cell proliferation (17). The free
Ca2+ acts as a proliferative signal for many normal
cells (18). Cytoplasmic calcium is also a pluripotent
regulator of cell function including the cell cycle and
apoptosis (19, 20). Thus, the agents that affect the
intracellular calcium level, could be considered as
important substances for cell functions, and we hy-
pothesized that bile acid activity on cellular prolifera-
tion leading to ACF formation may be in part through
the alteration of the intracellular calcium level. There-
fore, we aimed to assess the intracellular Ca2+ induc-
tion in rat a colon cancer cell line (ACL-15) by bile
acids, which are either promotive or suppressive/
ineffective in colonic ACF formation in rats.
MATERIALS AND METHODS
Chemicals
CA, CDCA and DCA were purchased from Sigma
Chemical Co. (St. Louis, MO). UDCA was from
Mitsubishi-Tokyo Pharmaceutical Co. Ltd. (Tokyo,
Japan). All the bile acids were sodium salt forms and
these were at least 97-99% pure according to the
manufacturer’s indications. AOM was purchased
from Sigma Chemicals Co. (St. Louis, MO). Fura-2-AMTM
was obtained fromDojindo Laboratories (Kumamoto,
Japan). Micro-cover glass (13 mm in diameter) was
obtained from Matsunami Glass Ind. Ltd. (Osaka,
Japan).
Animals
Six-week-old, male, F344 rats were purchased fromSLC
Co. (Hamamatsu, Japan) and housed in polycarbonate
cages with wood chips in a specific pathogen-free
laboratory of our animal facilities, three rats/cage.
They were kept under constant conditions of tem-
perature (22±2℃) and humidity (55±5%) with a
13 hr light/11 hr dark cycle. All the rats were provided
with laboratory chow basal diet (MF) (Oriental Yeast
Co. Ltd., Tokyo, Japan) unless specified and the beds
were changed twice a week. The arrival weight and
food consumption of the animals were recorded.
Study design
Study-1(Initiation and post-initiation)
Male F344 rats (6 weeks old) were treated with a
single dose of AOM (20 mg/kg, 10 mg/ml in sterile
saline) subcutaneously. Rats were allocated to one
of 3 experimental groups, the control and two UDCA
groups (initiation and post-initiation, 15-18 rats/group).
In the initiation group, the rats were fedMF (Orien-
tal Yeast, Co., Ltd., Tokyo, Japan) supplemented with
the UDCA (0.4%) ad libitum from four days before to
three days after the AOM injection (for 1 week), and
thereafter the rats were fed MF alone (Fig. 1 A). In
the post-initiation group, the MF was changed to a
UDCA-supplemented diet (0.4%) one week after AOM
injection (Fig. 1B). The control group was fed the MF
during the entire experimental period (Fig. 1C). Rats
(n=5-7) were sacrificed at the 2nd, 5th and 8th weeks.
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The isolated colons were collected and washed with
0.9% NaCl water solution. The lumen of the colon was
filled with 10% phosphate-buffered formalin (pH 7.4)
for 3 min. These were incised in a longitudinal direc-
tion and fixed flat between two pieces of filter paper
in the buffered formalin. The colons were stained
with 0.2% methylene blue (Sigma Chemical Co., St.
Louis, MO) and the number of ACF along the colon
was counted by their position in every 2 cm under
light microscope (21) from the anus to proximal
colon.
Study-2 (Time-course)
In this study, the rats (6 weeks old) were treated
with AOM as Study-1. One week later, the rats were
divided into two groups and were fed ad libitum the
MF diet supplemented with UDCA (0.4%) or MF
alone, until the end of the experiment (Fig. 1D). Rats
(n=4-5) were sacrificed at the 2nd, 4th, 8th, 16th
and 32nd weeks to count the colonic ACF.
Study-3 (Dose-response)
After treatment with AOM as a single dose andMF
feeding for 1 week, the rats were divided into five
groups (6 rats/group). From the beginning of the
second week rats were fed ad libitum the MF sup-
plemented with different concentrations of UDCA
(0.05%, 0.1%, 0.2% and 0.4%) or MF alone (Fig. 1E).
At the end of 5th week the rats were sacrificed to
evaluate the colonic ACF.
Statistical analyses in all studies were carried out
using analysis of variance (ANOVA), and P<0.05 was
considered significant.
Cell culture
The rat colon cancer cell line (ACL -15 cells) was
obtained from Riken Cell Bank (Tsukuba, Japan).
ACL-15 cells were grown in a 5% CO2-95% air humidi-
fied atmosphere at 37℃ and maintained for 3-5 days
as monolayer cultures in Dulbecco’s modified Eagle’s
minimum essential medium (DMEM ;Nissui, Tokyo,
Japan) supplemented with 10% fetal bovine serum
(FBS), 2 mM glutamine, penicillin (100 units/ml),
streptomycin (100 µg/ml) and gentamycin (40 µg/ml).
The cells were plated on 13 mm-diameter round cover
glasses in 35-mm culture dishes at a density of 1×
106 cells/dish.
Measurement of intracellular free [Ca2+]i
The cells were incubated at 37℃ for 30 min in 1 ml of
calcium containing phosphate-buffered saline PBS(+)/
4 µM fura-2/acetoxy methyl ester, a fluorescent Ca2+
indicator. Then, the cells on cover glasses were trans-
ferred to a small incubation bath (approx. 0.5 ml) that
was continuously rinsed with PBS(+) on the plat-
form of a microscope. Together with the onset of
Fig. 1 Study protocols. (A) Study-1 (initiation), (B) Study-1 (post-initiation), (C) Study-1 (control). Rats (5 -7 rats/group in each time
point) were sacrificed at the 2nd, 5th and 8th weeks. (D) Study-2 (time-course, 4 -5 rats/group at each time point were sacrificed).
(E) Study-3 (dose-response, 6 rats/dose-group). AOM ; azoxymethane, UDCA ; ursodeoxycholic acid, MF ; basal diet.
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the intracellular free Ca2+ concentration ([Ca2+]i) mea-
surement, PBS(+) rinsing the cells was immediately
replaced by 1 mM bile acid-containing PBS(+). Fluo-
rescence of the cells was measured using a fluores-
cence spectromicroscope (excitation, 340/380 nm ;
emission, 510 nm). About ten cells that showed ap-
parently normal morphological features, that were
isolated from surrounding cells were selected for
measurement in each bile acid case. The [Ca2+]i was
calculated using the previously reported equation
(22).
RESULTS
Effect of UDCA on ACF formation
In Study-1, the UDCA (0.4%) supplemented diet
decreased the ACF number both during the initia-
tion and post-initiation stages (Fig. 2A). After two
weeks of UDCA treatment, the ACF numbers in the
initiation and post-initiation groups decreased signifi-
cantly to 83.8% and 64.7% of the control group (av-
erage : 56.8 ACF/colon), respectively (P <0.01, P <
0.0001). At the 5th week of enumeration, the num-
bers in the initiation and post-initiation groups de-
creased to 82.3% and 87.0% of the control (average :
74.4 ACF/colon), respectively, but these suppressions
were not significant. At the 8th week, the ACF num-
bers in the initiation and post-initiation groups de-
creased significantly to 74.6% and 65.0% of the con-
trols (average : 92.0 ACF/colon), respectively (P <
0.001, P <0.0001). At the end of 8th week, the total
numbers of aberrant crypts (AC) in the initiation and
post-initiation groups showed decreasing tendencies
by 77.8% and 66.2% of the control (average : 283.0
AC/colon), respectively, but they were not signifi-
cantly different from controls.
In the time-course study (Study-2), the numbers
of ACF in the UDCA supplemented diet group were
46.0%, 70.7%, 85.1%, 66.4% and 82.5% of controls in
the 2nd, 4th, 8th, 16th and 32nd weeks, respective-
ly (Fig. 2B). The numbers of ACF decreased signifi-
cantly in the UDCA supplemented diet group at the
2nd (P<0.001), 4th (P<0.005) and 16th weeks (P<0.005),
but at the 32nd week, the ACF number was not sig-
nificantly decreased. The maximum suppressive ef-
fect of UDCA was observed at the 2nd week (46.0%
of controls), whereas it was minimum (82% of con-
trols) at the 32nd week, the end of the experiment.
In the dose-response study (Study-3), dietary ad-
ministration of UDCA decreased the number of ACF
in a dose-dependent manner. The suppressive effect
of UDCA on ACF formation was significant in UDCA
Fig. 2. Effect of ursodeoxycholic acid
(UDCA) on azoxymethane (AOM)-induced
aberrant crypt foci (ACF) formation in
the rat colon.
(A) Study-1 (□, control ; ◆, initiation ;
○, post-initiation). UDCA (0.4%) decreased
the number of ACF both in the initiation and
post-initiation stages of colon carcinogenesis.
(B) Study-2 (time-course) (□, control ;
◆, UDCA). (C) Study-3 (dose-response)
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of 0.1% (P <0.05), 0.2% (P <0.01) and 0.4% (P <0.005).
UDCA of 0.05% did not decrease the numbers of ACF
significantly (Fig. 2C).
Effect of bile acids on [Ca2+]i of ACL-15 cells
Measurement of intracellular Ca2+ by fluorescence
microscopy revealed that CDCA and DCA induced
a rapid increase in [Ca2+]i even when extracellular
Ca2+ was abolished (Fig. 3C-D). CDCA and DCA
(1 mM) increased [Ca2+]i to a peak of approximate-
ly 120 nM and 100 nM, respectively, followed by its
gradually decrease to a steady level. In contrast, UDCA
and CA did not induce an increase in [Ca2+]i (Fig.
3A-B).
DISCUSSION
In our previous studies, we found that UDCA sup-
pressed the carcinogen-induced colonic ACF forma-
tion in rats (6, 7). In the present study, we also ob-
served an ACF-suppressive effect of UDCA. To observe
the ACF suppressive effect of UDCA in detail, we
investigated the effect of UDCA on ACF using differ-
ent protocols. In study-1A of the present study, it was
shown that UDCA could decrease the AOM-induced
ACF number during the initiation as well as during
the post-initiation, suggesting that UDCA affects both
stages of colon carcinogenesis. In the time-course
study that examined the long-term effect of UDCA,
we found that UDCA continued to significantly sup-
press the ACF number compared with controls until
the 16th week of the experiment (70.8 vs. 106.6), at
the 32nd week the ACF number of UDCA and MF
fed groups (60.0 vs. 72.7 ACF/colon) did not differ
so much as the early period of the experiment. In
the present dose-response study of UDCA we ob-
served that the MF diet supplemented with 0.05%
and 0.1% of UDCA suppressed the ACF number gradu-
ally, but unexpectedly this suppressive effect of UDCA
did not increase so markedly at doses higher than
0.1%. The exact cause(s) of these variable effects of
UDCA remains to be clarified. However, it was re-
ported that orally supplemented bile acids are frequent-
ly converted to other bile acids by the enterohepatic
circulation as well as by enzymatic action of gut flora
(7, 23, 24). In our previous study with dietary admin-
istration of UDCA and other bile acids, the fecal bile
acids analysis revealed that similar to other bile acids,
UDCA was also converted to muricholic acid (50.8%),
LCA (10.2%), hydodeoxycholic acid (8.7%), DCA (4.1%),
CDCA (0.4%) and others (7). These converted acids
are known as ACF promoting bile acids and this con-
version was suggested to be changed in terms of qual-
ity and quantity in long-term administration. This
may be one of the causes for UDCA not to continue
its ACF suppressive effect beyond a certain dose and
time. Moreover, rat colonic mucosal cellsmay change
Fig. 3. Effect of bile acids on [Ca2+]i in ACL-15
cells. (A) UDCA, (B) CA, (C) CDCA, (D) DCA.
Time 0 indicates when the bile acid (1 mM)
contacted the cells. Each value indicates the
“mean±SD” of about ten cells measured.
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their response to UDCA after long-term administra-
tion.
The mechanism(s) involved in tumor promotion
by bile acids remains unclear. Similarly, the mecha-
nisms involved in the anticarcinogenic effects of
UDCA on experimental colonic cancer also remain
to be clarified. Alterations in protein kinase C (PKC)
are involved in colonic malignant transformation in
humans (14) and in animals (15). PKC constitutes
a gene family of serine/threonine protein kinases
that play central roles in transmembrane signaling
events, and are involved in diverse biological processes,
including cellular proliferation and differentiation
(25). Bile acids, which are known as activators of PKC
(16), can also stimulate the membrane phospholipase
C that converts the phosphatidylinositol biphosphate
to inositol triphosphate (IP3) and diacylglycerol (DAG).
IP3 acts on endoplasmic reticulum and this released
calcium ions into the cytoplasm. These calcium ions
in addition to the DAG, ultimately activate the PKC
for further activities. Therefore, bile acids can acti-
vate the PKC via the induction of intracellular cal-
cium ions. In the present study, CDCA and DCA
which were previously reported to increase the num-
ber of ACF in the rat colon (6, 7), induced a rapid
increase in the [Ca2+]i in ACL-15 cells. Thus, the ACF
promotive effect of CDCA and DCA in animal model
studies agrees with the present in vitro finding of
their calcium ion induction. From this result we can
say that the effect of CDCA and DCAmay be, in part,
related to the increase in [Ca2+]i. However, CA, which
showed no effect (7) or suppressive effect (26) on
ACF formation, and UDCA, which suppressed the
ACF number (6, 7), did not show any effect on [Ca2+]i.
Although the ineffective nature of the CA on colonic
ACF formation is consistent with its effect of unchanged
[Ca2+]i, the suppressive effect of CA and UDCA on
ACF formation is not correlated with their [Ca2+]i
induction. Other mechanism(s) in this suppression
process may be involved and remain to be clarified.
In conclusion, regardless of the exact mechanism(s)
of bile acids to produce colonic ACF, the present find-
ings demonstrated that the ACF promotive activity
of bile acids in rat colonic mucosa may be through
the involvement of PKC that is activated partly by
intracellular calcium ions. Therefore, it is suggested that
there is a possible relation between the intracellular
calcium ion induction by bile acids and the effects
of bile acids on ACF formation.
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